159 related articles for article (PubMed ID: 25153995)
1. Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction--is it associated with depressive symptomatology?
Jönsson S; Lundberg AK; Jonasson L
PLoS One; 2014; 9(8):e105572. PubMed ID: 25153995
[TBL] [Abstract][Full Text] [Related]
2. Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction.
Mukherjee R; Snipes JM; Saunders SM; Zavadzkas JA; Spinale FG
J Surg Res; 2012 Jan; 172(1):59-67. PubMed ID: 20863528
[TBL] [Abstract][Full Text] [Related]
3. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
4. Effect of warming Yang and removing blood stasis method on matrix metalloproteinases / tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis.
Huang Y; Shen L; Cai A; Xiao J
J Tradit Chin Med; 2015 Oct; 35(5):571-6. PubMed ID: 26591688
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2), and EMMPRIN (CD147) in multiple myeloma.
Urbaniak-Kujda D; Kapelko-Slowik K; Prajs I; Dybko J; Wolowiec D; Biernat M; Slowik M; Kuliczkowski K
Hematology; 2016 Jan; 21(1):26-33. PubMed ID: 26268417
[TBL] [Abstract][Full Text] [Related]
6. Salivary MMPs, TIMPs, and MPO levels in periodontal disease patients and controls.
Meschiari CA; Marcaccini AM; Santos Moura BC; Zuardi LR; Tanus-Santos JE; Gerlach RF
Clin Chim Acta; 2013 Jun; 421():140-6. PubMed ID: 23501330
[TBL] [Abstract][Full Text] [Related]
7. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
9. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
Horne BD; Camp NJ; Carlquist JF; Muhlestein JB; Kolek MJ; Nicholas ZP; Anderson JL
Am Heart J; 2007 Oct; 154(4):751-8. PubMed ID: 17893005
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas.
Zhang X; Wang Y; Yamamoto G; Tachikawa T
Histopathology; 2009 Sep; 55(3):250-60. PubMed ID: 19723139
[TBL] [Abstract][Full Text] [Related]
11. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
12. Expression of the matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in systemic lupus erythematosus patients.
Vira HJ; Pradhan VD; Umare VD; Chaudhary AK; Rajadhyksha AG; Nadkar MY; Ghosh K; Nadkarni AH
Neth J Med; 2020 Sep; 78(5):261-268. PubMed ID: 33093251
[TBL] [Abstract][Full Text] [Related]
13. Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
Rathnayake N; Gustafsson A; Norhammar A; Kjellström B; Klinge B; Rydén L; Tervahartiala T; Sorsa T;
PLoS One; 2015; 10(7):e0126370. PubMed ID: 26132583
[TBL] [Abstract][Full Text] [Related]
14. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris.
Jönsson S; Lundberg A; Kälvegren H; Bergström I; Szymanowski A; Jonasson L
PLoS One; 2011 Apr; 6(4):e19340. PubMed ID: 21559401
[TBL] [Abstract][Full Text] [Related]
16. TIMP-1 expression in coronary thrombi associate with myocardial injury in ST-elevation myocardial infarction patients.
Nordeng J; Schandiz H; Solheim S; Åkra S; Hoffman P; Roald B; Bendz B; Arnesen H; Helseth R; Seljeflot I
Coron Artery Dis; 2022 Sep; 33(6):446-455. PubMed ID: 35102064
[TBL] [Abstract][Full Text] [Related]
17. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
18. Investigating the expression of MMPs and TIMPs in preterm placenta and role of CpG methylation in regulating MMP-9 expression.
Sundrani D; Narang A; Mehendale S; Joshi S; Chavan-Gautam P
IUBMB Life; 2017 Dec; 69(12):985-993. PubMed ID: 29130646
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis.
Kouwenhoven M; Ozenci V; Tjernlund A; Pashenkov M; Homman M; Press R; Link H
J Neuroimmunol; 2002 May; 126(1-2):161-71. PubMed ID: 12020967
[TBL] [Abstract][Full Text] [Related]
20. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
